Clinical Trial Update: Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma [NA]

View source ↗

Summary

A completed clinical trial of microparticle enhanced cytotoxic transarterial embolization therapy for hepatocellular carcinoma has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Hepatocellular Carcinoma | NA | Status: COMPLETED | Results posted: 2016-06-27